Investment Newsletters
Home
Top Nasdaq Stocks
Cannabis-Stock Buzz
Analyst Insights
All Sectors
Biotech Stocks
Technology Stocks
Consumer Stocks
Industrial Stocks
Financial Stocks
Stock News
All Sectors
Biotech Stocks
Technology stocks
Consumer Stocks
Industrial Stocks
Financial Stocks
Bloggers Corner
Investment newsletters
The Daily Insider
Bio Portfolio
The Big Short
Small-Cap Rockets
Go Sector
Investment newsletters
The Daily Insider
Bio Portfolio
The Big Short
Small-Cap Rockets
Go Sector
Guru Portfolio
Amgen Inc
Retrophin’s Busy Week: A Financing, a Drug Approval and a Valuable FDA Voucher
Just a day after Retrophin Inc. (NASDAQ:RTRX) announced a $100 million financing the U.
PropThink
—
March 18, 2015, 9:24 AM EDT
«
1
2
3
4
x
Stay Ahead of Everyone Else
Get The Latest
Stock News Alerts
